August 15, 2023
Hospital pharmacists are facing major headwinds obtaining certain medications as drug shortages approach all-time highs, according to a new survey from the American Society of Health-System Pharmacists (ASHP).
The survey, released last week, indicates that 57 percent of hospital and health system pharmacists reported critical shortages for chemotherapy drugs. The survey also indicates significant shortages for steroids, hormonal drugs, amoxicillin, and lidocaine.
Drug shortages have been a discussion point throughout 2023. A U.S. Senate committee report outlined several factors including “economic drivers, insufficient supply chain visibility, and a continued U.S. overreliance on both foreign and geographically concentrated sources for medications.” The report noted the “cascading effects” for patient care, such as care delays, medication errors, and less effective treatments.
"Pharmacists have been managing drug shortages routinely for decades, but we’re now seeing longer, more persistent shortages,” said ASHP Chief Executive Officer Paul W. Abramowitz. “We’re facing shortages for more than 300 drugs, and that trajectory is growing. This reality is unsustainable for hospitals and patients alike.”
Among the key takeaways from the ASHP survey:
HAP continues to monitor trends in the health care drug supply and provide updates to members. The ASHP survey is available online.
Tags: Access to Care
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.